TY  - JOUR 
AU  - Corral Alaejos, Álvaro
AU  - Zarzuelo Castañeda, Aránzazu
AU  - Jiménez Cabrera, Silvia
AU  - Sánchez Guijo Martín, Fermín
AU  - Otero López, María José
AU  - Pérez Blanco, Jonás Samuel
PY  - 2021
SN  - 0306-5251
UR  - http://hdl.handle.net/10366/162158
AB  - Imatinib is considered the standard first-line treatment in newly diagnosed patients with chronic-phase myeloid leukaemia (CML). Several imatinib population pharmacokinetic (popPK) models have been developed. However, their predictive performance has...
LA  - eng
PB  - John Wiley&Sons
KW  - Cancer
KW  - NONMEM
KW  - Pharmacometrics
KW  - Population analysis
KW  - Therapeutic drug monitoring
TI  - External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia
DO  - 10.1111/bcp.15122
T2  - British Journal of Clinical Pharmacology
VL  - 88
M2  - 1913
ER  -